HONORS AND AWARDS
• Kaiser Award for Outstanding and Innovative Contributions to Medical Education, The Henry J. Kaiser Family Foundation (1983) • Ross Young Investigator Award, Western Society for Pediatric Research (1990) • American Academy of Pediatrics Award for Excellence in Pediatric Research, American Academy of Pediatrics (1991) • The Duane Alexander Award for Academic Leadership in Perinatal Medicine, The National Institute of Child Health and Human Development (2003) • Advisor of Highest Distinction for Exemplary Contributions to Undergraduate Education, Stanford University (2004) • MENTOR Award for Excellence in Research Training, The National Institute of Child Health and Human Development (2004) • The Neonatal Education Award in Perinatal Pediatrics, American Academy of Pediatrics (2004) • Virginia Apgar Award in Perinatal Pediatrics, American Academy of Pediatrics (2006) • Albion Walter Hewlett Award, Stanford University School of Medicine (2009 
BOARDS, ADVISORY COMMITTEES, PROFESSIONAL ORGANIZATIONS
• Secretary-Treasurer, Western Society for Pediatric Research (1986 Research ( -1990 • Committee on Awards for Excellence in Pediatric Research, American Academy of Pediatrics (1987 Pediatrics ( -1991 • Member, Ross Laboratory Seminars on Perinatal Medicine Advisory Board (1987 Board ( -1995 • Neonatal-Perinatal Examination Committee, American Board of Pediatrics (1990 Pediatrics ( -1996 • Member, American Academy of Pediatrics Executive Committee, Section on Perinatal Pediatrics (1991 Pediatrics ( -1998 • Chair, American Academy of Pediatrics Executive Committee, Section on Perinatal Pediatrics ( -1996 • Member, March of Dimes Basil O'Connor Advisory Committee (1995 -2002) • President, Western Society for Pediatric • Liaison Member for Section on Perinatal Pediatrics, Committee on Fetus and Newborn (COFN), American Academy of Pediatrics (1997 Pediatrics ( -1998 • Chair, Western Conference for Perinatal Research, (Mead Johnson Nutritionals) (1997 -2002) • Member, Sub-Board of Neonatal-Perinatal Medicine (1997 • Member, Council of the American Pediatric Society (1997 • President, California Association of Neonatologists (CAN) (1999 -2000) • Chair, Sub-Board of Neonatal-Perinatal Medicine, American Board of Pediatrics (2000 Pediatrics ( -2002 • Program Chair, Pediatric Academic Societies Annual Meeting (2000 -2003) • Vice President/President-Elect, American Pediatric Society (2004 -2005 • Board of Directors, American Board of Pediatrics (2004 Pediatrics ( -2009 • President, American Pediatric Society (2005 • Board of Directors, Children's Health Council (2005 -2008 • Scientific Advisory Board, Faculty of Pharmacy, University of Lisboa, Portugal (2007 -present) • Chair, Long Range Planning Committee, American Board of Pediatrics (2009 Pediatrics ( -2013 • Task Force on Subspecialty Training and Certification, American Board of Pediatrics (2010 Pediatrics ( -2013 • Maureen Andrew Mentor Award Selection Committee, Society for Pediatric Research (2011 Research ( -2013 • Affiliated Faculty Member, Woods Institute (2011 -present) • Chair, Maureen Andrew Mentor Award Selection Committee, Society for Pediatric Research (2013 Research ( -2013 • Transdisciplinary Centers (TDC) Advisory Committee, Ex Officio Member, March of Dimes (2013 -present) • Guest Professor, Juntendo University, Tokyo, Japan (2015 -present)
PROFESSIONAL EDUCATION
• Board Certification: Neonatal-Perinatal Medicine, American Board of Pediatrics (1979) • Board Certification: Pediatrics, American Board of Pediatrics (1979) • 
Research & Scholarship CURRENT RESEARCH AND SCHOLARLY INTERESTS
Our research is focused on the study of the ontogeny and control of heme catabolism and bilirubin production in the developing neonate. A better understanding of the role of increased bilirubin production in neonatal jaundice and the prevention of hemolytic jaundice has remained an overall objective of our program. To this end, we are actively investigating a more targeted, preventive approach to the diagnosis and treatment of newborns, who are high producers of the pigment and/or unable to efficiently eliminate bilirubin, thus leading to an accumulation of the pigment in circulation and tissues, which may lead to irreversible neurologic injury. Control of bilirubin production is a logical strategy, but has unexplored consequences for the immature mammal. Thus, we are studying the pivotal role of heme oxygenase (HO), the rate-limiting enzyme in the production of bilirubin, under a variety of commonly encountered pathological conditions, such as infection and hypoxia-ischemia, as well as in anti-oxidant defense, immune response and the regulation of hematopoiesis. In support of the above interests, studies are in progress, which are designed to screen a variety of metalloporphyrins and other compounds for maximum in vitro and in vivo efficacy with minimal side effects; to determine the ontogeny of the HO enzyme system in various murine tissues, focusing on perturbations resulting from treatment with HO inhibitors; and further to develop and test new technologies for noninvasive or minimally-invasive measurements of in vivo metabolism that could be used for diagnostic and monitoring purposes. 
